Last reviewed · How we verify

Kava

Masonic Cancer Center, University of Minnesota · FDA-approved active Small molecule

Kava contains kavalactones that modulate neurotransmitter activity and may have anxiolytic and anti-inflammatory properties.

Kava contains kavalactones that modulate neurotransmitter activity and may have anxiolytic and anti-inflammatory properties. Used for Anxiety and stress management in cancer patients (supportive care).

At a glance

Generic nameKava
Also known asNo brand name
SponsorMasonic Cancer Center, University of Minnesota
Drug classHerbal supplement / botanical extract
ModalitySmall molecule
Therapeutic areaSupportive/Palliative Care
PhaseFDA-approved

Mechanism of action

Kava is a plant-derived herbal preparation whose active constituents (kavalactones) interact with multiple neurological pathways, including GABA receptors and monoamine systems, producing sedative and anxiolytic effects. The exact mechanism remains incompletely characterized, but kavalactones appear to enhance GABAergic neurotransmission and modulate dopamine and serotonin signaling. In the context of cancer care, kava has been studied for potential supportive use in managing anxiety and stress-related symptoms in cancer patients.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results